Amelioration of collagen-induced arthritis in rats by nanogold.

OBJECTIVE Angiogenesis plays a part in the pathogenesis of rheumatoid arthritis (RA), and nanogold inhibits the activity of an angiogenic factor, vascular endothelial growth factor (VEGF). We therefore investigated whether intraarticular delivery of nanogold ameliorates collagen-induced arthritis (CIA) in rats. METHODS Binding of 13-nm nanogold to VEGF in human RA synovial fluid (SF) and its effects on RA SF-induced endothelial cell proliferation and migration were assessed. Nanogold was administered intraarticularly to rats with CIA before the onset of arthritis. Progression of CIA was monitored by measures of clinical, radiologic, and histologic changes. In addition, the microvessel density and extent of infiltrating macrophages as well as levels of tumor necrosis factor alpha (TNFalpha) and interleukin-1beta (IL-1beta) in the ankle joints were determined. RESULTS Nanogold bound to VEGF in RA SF, resulting in inhibition of RA SF-induced endothelial cell proliferation and migration. Significant reductions in ankle circumference, articular index scores, and radiographic scores were observed in the nanogold-treated rats with CIA compared with their control counterparts. In addition, the histologic score (of synovial hyperplasia, cartilage erosion, and leukocyte infiltration), microvessel density, macrophage infiltration, and levels of TNFalpha and IL-1beta were also significantly reduced in the ankle joints of nanogold-treated rats. CONCLUSION Our results are the first to demonstrate that intraarticular administration of nanogold ameliorates the clinical course of CIA in rats. Nanogold exerted antiangiogenic activities and subsequently reduced macrophage infiltration and inflammation, which resulted in attenuation of arthritis. These results demonstrate proof of principle for the use of nanogold as a novel therapeutic agent for the treatment of RA.

[1]  S. S. Lee,et al.  Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. , 2001, Clinical and experimental rheumatology.

[2]  M. Ferrari,et al.  Proteins and cells on PEG immobilized silicon surfaces. , 1998, Biomaterials.

[3]  D. Heinegård,et al.  Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. , 1988, Arthritis and rheumatism.

[4]  B. Berse,et al.  Hypoxia augments cytokine (transforming growth factor‐beta (TGF‐β) and IL‐1)‐induced vascular endothelial growth factor secretion by human synovial fibroblasts , 1999, Clinical and experimental immunology.

[5]  I. Jou,et al.  Thrombospondin 1 as an effective gene therapeutic strategy in collagen-induced arthritis. , 2005, Arthritis and rheumatism.

[6]  B Merchant,et al.  Gold, the noble metal and the paradoxes of its toxicology. , 1998, Biologicals : journal of the International Association of Biological Standardization.

[7]  A. Koch,et al.  Angiogenesis as a target in rheumatoid arthritis , 2003, Annals of the rheumatic diseases.

[8]  M. Jayson,et al.  Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1. , 1988, Clinical and experimental immunology.

[9]  T. Pufe,et al.  Splice variants VEGF121 and VEGF165 of the angiogenic peptide vascular endothelial cell growth factor are expressed in the synovial tissue of patients with rheumatoid arthritis. , 2001, The Journal of rheumatology.

[10]  L. Chao,et al.  Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation. , 2005, Arthritis and rheumatism.

[11]  A. Koch,et al.  Evidence of IL-18 as a Novel Angiogenic Mediator1 , 2001, The Journal of Immunology.

[12]  A. Koch,et al.  Angiogenesis in rheumatoid arthritis , 2009, Autoimmunity.

[13]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[14]  Y. Iwamoto,et al.  Fibroblast Growth Factor-2 Determines Severity of Joint Disease in Adjuvant-Induced Arthritis in Rats , 2002, The Journal of Immunology.

[15]  J. Hainfeld,et al.  The use of gold nanoparticles to enhance radiotherapy in mice. , 2004, Physics in medicine and biology.

[16]  J. Storhoff,et al.  A DNA-based method for rationally assembling nanoparticles into macroscopic materials , 1996, Nature.

[17]  Jonathan S Dordick,et al.  Silica nanoparticle size influences the structure and enzymatic activity of adsorbed lysozyme. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[18]  E. Paleolog.  Angiogenesis in rheumatoid arthritis , 2002, Arthritis research.

[19]  M. Nagashima,et al.  Effects of combinations of anti-rheumatic drugs on the production of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis. , 2000, Rheumatology.

[20]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[21]  R. G. Freeman,et al.  Preparation and Characterization of Au Colloid Monolayers , 1995 .

[22]  R. Moskowitz,et al.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. , 1986, Arthritis and rheumatism.

[23]  M. Adachi,et al.  Vascular Endothelial Growth Factor Expression and Regulation of Murine Collagen-Induced Arthritis1 , 2000, The Journal of Immunology.

[24]  M. Sastry,et al.  Capping of Gold Nanoparticles by the Amino Acid Lysine Renders Them Water-Dispersible , 2003 .

[25]  P. Schultz,et al.  Organization of 'nanocrystal molecules' using DNA , 1996, Nature.

[26]  Lon A. Porter,et al.  Gold and Silver Nanoparticles Functionalized by the Adsorption of Dialkyl Disulfides. , 1998, Langmuir : the ACS journal of surfaces and colloids.

[27]  Anthony Atala,et al.  Gold Nanoparticles Inhibit VEGF165-Induced Proliferation of HUVEC Cells , 2004 .

[28]  Hung V. Nguyen,et al.  The Carboxyl-terminal Domain(111165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency (*) , 1996, The Journal of Biological Chemistry.

[29]  Chi-Bom Chae,et al.  Arginine-Rich Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Hexapeptide Inhibits Collagen-Induced Arthritis and VEGF-Stimulated Productions of TNF-α and IL-6 by Human Monocytes 1 , 2005, The Journal of Immunology.

[30]  Dar-Bin Shieh,et al.  A biological strategy for fabrication of Au/EGFP nanoparticle conjugates retaining bioactivity , 2004 .

[31]  Irshad Hussain,et al.  Rational and combinatorial design of peptide capping ligands for gold nanoparticles. , 2004, Journal of the American Chemical Society.

[32]  Ling Wang,et al.  Antiangiogenic Properties of Gold Nanoparticles , 2005, Clinical Cancer Research.

[33]  B. Bresnihan,et al.  Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis. , 1991, Annals of the rheumatic diseases.

[34]  J. Fiddes,et al.  The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. , 1991, The Journal of biological chemistry.

[35]  N. Olsen,et al.  Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue , 1994, The Journal of experimental medicine.

[36]  B. Jonsson,et al.  Adsorption of Human Carbonic Anhydrase II Variants to Silica Nanoparticles Occur Stepwise: Binding Is Followed by Successive Conformational Changes to a Molten-Globule-like State , 2000 .

[37]  Bottomley,et al.  Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up‐regulation by tumour necrosis factor‐alpha (TNF‐α) in synovial fluid , 1999, Clinical and experimental immunology.

[38]  I. Cohen,et al.  Angiogenesis-Inflammation Cross-Talk: Vascular Endothelial Growth Factor Is Secreted by Activated T Cells and Induces Th1 Polarization , 2004, The Journal of Immunology.

[39]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[40]  Michele Follen,et al.  Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. , 2003, Cancer research.

[41]  Y. Okada,et al.  Expression of vascular endothelial growth factor isoforms and their receptors Flt‐1, KDR, and neuropilin‐1 in synovial tissues of rheumatoid arthritis , 2000, The Journal of pathology.

[42]  P Rolfe,et al.  Physical and biological properties of compound membranes incorporating a copolymer with a phosphorylcholine head group. , 1998, Biomaterials.

[43]  G. Haines,et al.  Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. , 1994, Journal of immunology.

[44]  Bengt-Harald Jonsson,et al.  Protein adsorption onto silica nanoparticles: conformational changes depend on the particles' curvature and the protein stability. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[45]  J. Jackson,et al.  Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1beta. , 1997, The Journal of rheumatology.

[46]  R. Shukla,et al.  Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[47]  Shaojun Dong,et al.  Effect of colloidal gold size on the conformational changes of adsorbed cytochrome c: probing by circular dichroism, UV-visible, and infrared spectroscopy. , 2005, Biomacromolecules.